Modern cold calling for agencies: how to productise the offering for healthcare and life sciences in the Nordics
The service design, pricing, and delivery model for running modern cold calling as a productised offering inside a services firm. Written for commercial leaders at healthtech, medtech, and life-sciences companies in the Nordics.
This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in the Nordics. In this market, Nordic buyers reward directness, small buying committees, and a track record over a pitch, so the way you install modern cold calling has to be shaped to that reality from day one.
Modern cold calling is one of the highest-margin offerings an agency can add in 2026. It is using the phone as a precision tool, not a volume weapon, and clients will pay a premium for the discipline they cannot install themselves.
Productise around outcome, not activity. Sell connects per hour on ICP dials moving to a defined level in a defined window, not a monthly retainer of vague ops.
Delivery pod: one strategist, one operator, one editor. Fewer people than that risks quality; more than that dilutes margin.
Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in the Nordics it is compounded by the fact that reputation compounding, not campaign spend is what actually gates growth. Modern cold calling is only useful here when it is pointed at both constraints at once.
Onboarding takes two weeks: diagnosis, list build, trigger definition, kill criteria. Do not ship anything live before the diagnosis is signed off.
Pricing: outcome-linked base plus a monthly ops fee. The base rewards results; the ops fee funds the delivery pod.
Client failure mode: power dialers that torch the list in a week. Write it into the engagement letter as a shared risk, not something you absorb quietly.
The agencies making the most from modern cold calling are the ones with the tightest playbook. Documented, versioned, and improved every quarter.
Concretely for healthcare and life sciences in the Nordics: the healthcare teams that install this get past procurement instead of dying in it, and the Nordic teams that install this compound reputation faster than any paid channel could. That is the reason it is worth installing modern cold calling deliberately for this market rather than importing a playbook designed for somewhere else.
Frequently asked questions
Sales · healthcare · Nordics — answered
- Does modern cold calling work for healthcare and life sciences in the Nordics?
- Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in the Nordics, Nordic buyers reward directness, small buying committees, and a track record over a pitch. The healthcare teams that install this get past procurement instead of dying in it.
- How should agencies price modern cold calling?
- Outcome-linked base plus a monthly ops fee. Avoid pure retainer.
- What is the minimum delivery pod?
- Strategist, operator, editor. Three roles, not necessarily three headcount at small scale.
- How long is agency onboarding for modern cold calling?
- Two weeks: diagnosis, list, trigger, kill criteria.
- What client behaviour breaks the engagement?
- Power dialers that torch the list in a week — bake shared risk into the contract.
- What is the Nordics-specific pitfall when running modern cold calling for healthcare?
- Importing a playbook that was built for another market. In the Nordics, Nordic buyers reward directness, small buying committees, and a track record over a pitch — the install has to reflect that.
Growth Broker editorial
Filed under sales · healthcare · nordics